Skip to main content
×
Home
Physical Illness and Schizophrenia
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 18
  • Cited by
    This book has been cited by the following publications. This list is generated based on data provided by CrossRef.

    De Rosa, Corrado Sampogna, Gaia Luciano, Mario Del Vecchio, Valeria Pocai, Benedetta Borriello, Giuseppina Giallonardo, Vincenzo Savorani, Micaela Pinna, Federica Pompili, Maurizio and Fiorillo, Andrea 2017. Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions. Expert Review of Neurotherapeutics, Vol. 17, p. 667.


    Swain, SaradaPrasanna Behura, SushreeSangita Dash, ManojKumar Nayak, AnilKumar and Pati, SaswatiSucharita 2017. The influence of psychosocial dysfunctions in chronic schizophrenia patients in remission: A hospital-based study. Indian Journal of Psychological Medicine, Vol. 39, p. 157.


    Brown, James S. 2016. Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia. Schizophrenia Bulletin, Vol. 42, p. 1407.


    Franczak, Michael Barshter, Doug Reich, John W. Kent, Martha and Zautra, Alex J. 2016. Handbook of Recovery in Inpatient Psychiatry. p. 409.

    O'Brien, C. Gardner-Sood, P. Corlett, S. K. Ismail, K. Smith, S. Atakan, Z. Greenwood, K. Joseph, C. and Gaughran, F. 2014. Provision of health promotion programmes to people with serious mental illness: a mapping exercise of four South London boroughs. Journal of Psychiatric and Mental Health Nursing, Vol. 21, p. 121.


    Burti, Lorenzo Berti, Loretta Bonfioli, Elena and Fiorini, Irene 2013. Improving Mental Health Care. p. 114.

    Papanastasiou, Evangelos 2013. The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review. Therapeutic Advances in Psychopharmacology, Vol. 3, p. 33.


    Robson, Debbie Haddad, Mark Gray, Richard and Gournay, Kevin 2013. Mental health nursing and physical health care: A cross-sectional study of nurses' attitudes, practice, and perceived training needs for the physical health care of people with severe mental illness. International Journal of Mental Health Nursing, Vol. 22, p. 409.


    Cookson, John Hodgson, Richard and Wildgust, Hiram J 2012. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis. Journal of Psychopharmacology, Vol. 26, p. 42.


    Papanastasiou, Evangelos 2012. Interventions for the metabolic syndrome in schizophrenia: a review. Therapeutic Advances in Endocrinology and Metabolism, Vol. 3, p. 141.


    Papanastasiou, Evangelos Gaughran, Fiona and Smith, Shubulade 2011. Schizophrenia as segmental progeria. Journal of the Royal Society of Medicine, Vol. 104, p. 475.


    DE HERT, MARC CORRELL, CHRISTOPH U. BOBES, JULIO CETKOVICH-BAKMAS, MARCELO COHEN, DAN ASAI, ITSUO DETRAUX, JOHAN GAUTAM, SHIV MÖLLER, HANS-JURGEN NDETEI, DAVID M. NEWCOMER, JOHN W. UWAKWE, RICHARD and LEUCHT, STEFAN 2011. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, Vol. 10, p. 52.


    Sartorius, Norman 2011. Notes of a traveller. Acta Psychiatrica Scandinavica, Vol. 123, p. 239.


    Lawrence, David Kisely, Stephen and Pais, Joanne 2010. The Epidemiology of Excess Mortality in People with Mental Illness. The Canadian Journal of Psychiatry, Vol. 55, p. 752.


    Guha, Martin 2009. Book Review: NEUROANALYSIS: BRIDGING THE GAP BETWEEN NEUROSCIENCE, PSYCHOANALYSIS AND PSYCHIATRY By Avi Peled, Routledge, 2008. 150pp. Pb. £20.99 ISBN 978—0-415—45133—8 THE ROLE OF RELIGION IN MARRIAGE AND FAMILY COUNSELLING Edited by Jill Duba Onedera, Routledge, 2007. 304pp. Hb. £24.95 ISBN 978—0-415—95499—1 JACK NICHOLS, GAY PIONEER: “HAVE YOU HEARD MY MESSAGE?” By J. Louis Campbell, Haworth Press, 2007. 346pp. Hb. £60.00 ISBN 978—1-56023—653—5. International Journal of Social Psychiatry, Vol. 55, p. 92.


    Weiser, Prisca Becker, Thomas Losert, Carolin Alptekin, Köksal Berti, Loretta Burti, Lorenzo Burton, Alexandra Dernovsek, Mojca Dragomirecka, Eva Freidl, Marion Friedrich, Fabian Genova, Aneta Germanavicius, Arunas Halis, Ulaş Henderson, John Hjorth, Peter Lai, Taavi Larsen, Jens Ivar Lech, Katarzyna Lucas, Ramona Marginean, Roxana McDaid, David Mladenova, Maya Munk-Jørgensen, Povl Paziuc, Alexandru Paziuc, Petronela Priebe, Stefan Prot-Klinger, Katarzyna Wancata, Johannes and Kilian, Reinhold 2009. European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods. BMC Public Health, Vol. 9,


    Oud, Marian JT and Meyboom-de Jong, Betty 2009. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Family Practice, Vol. 10,


    Leucht, S. Burkard, T. Henderson, J. Maj, M. and Sartorius, N. 2007. Physical illness and schizophrenia: a review of the literature. Acta Psychiatrica Scandinavica, Vol. 116, p. 317.


    ×

Book description

It is well established that people suffering from schizophrenia have a higher prevalence of serious physical illness and a higher mortality than the general population. This book provides the first comprehensive and systematic review of current research evidence on the prevalence of physical diseases in people with schizophrenia, a disorder afflicting approximately 1% of the global population, and a group with mortality rates twice as high as the general population. The epidemiological data described in this book will provide the basis for improved awareness of these problems and better treatment for patients. This is the first in a series of books addressing an issue emerging as a priority in the mental health field: the timely and proper recognition of physical health problems in people with mental disorders. They should be read by policy makers, service managers, mental health professionals and general practitioners.

Reviews

'… a quick and easy reference guide and a good starting point for trainees and readers interested in co-morbidity…'

Source: Journal of Psychological Medicine

'This book is well worth looking at: a forceful reminder to clinicians not to focus too narrowly on the mental disorders of patients who are twice as likely to be suffering from something else as well.'

Source: Journal of Mental Health

'… beyond its enormous merit in giving more salience to the issue of physical comorbidity in patients with schizophrenia, the book of Leuch et al. will hopefully ignite a new global research offensive in this field. The book is certainly uniquely suited to achieving this task.'

Source: Journal of Psychosomatic Research

    • Aa
    • Aa
Refine List
Actions for selected content:
Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Send to Kindle
  • Send to Dropbox
  • Send to Google Drive
  • Send content to

    To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to .

    To send content to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

    Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

    Find out more about the Kindle Personal Document Service.

    Please be advised that item(s) you selected are not available.
    You are about to send:
    ×

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
×
G. Abraham , W. W. Paing , J. Kaminski et al. (2003) Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study. Am. J. Psychiatry 160, 1618–1620.

A. Aleman , R. S. Kahn , J. P. Selten (2003) Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry 60, 565–571.

P. Allebeck (1989) Schizophrenia: a life-shortening disease. Schizophr. Bull. 15, 81–89.

P. Allebeck , Y. Rodvall , B. Wistedt (1985) Incidence of rheumatoid arthritis among patients with schizophrenia, affective psychosis and neurosis. Acta Psychiatr. Scand. 71, 615–619.

D. B. Allison , K. R. Fontaine , M. Heo et al. (1999a) The distribution of body mass index among individuals with and without schizophrenia. J. Clin. Psychiatry 60, 215–220.

American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596–601.

K. Ataya , A. Mercado , J. Kartaginer , A. Abbasi , K. S. Moghissi (1988) Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil. Steril. 50, 876–881.

J. L. Ayuso-Mateos , F. Montanes , I. Lastra , d.l.G. Picazo , J. L. Ayuso-Gutierrez (1997) human immunodeficiency virus infection in psychiatric patients: an unlinked anonymous study. Br. J. Psychiatry 170, 181–185.

P. C. Baastrup , C. Christiansen , I. Transbol (1980) Calcium metabolism in schizophrenic patients on long-term neuroleptic therapy. Neuropsychobiology 6, 56–59.

M. Bagedahl-Strindlund (1986) Mentally ill mothers and their children: an epidemiological study of antenatal care consumption, obstetric conditions, and neonatal health. Acta Psychiatr. Scand. 74, 32–40.

J. Baillargeon , S. Ducate , J. Pulvino et al. (2003) The association of psychiatric disorders and human immunodeficiency virus infection in the correctional setting. Ann. Epidemiol. 13, 606–612.

J. A. Baldwin (1979) Schizophrenia and physical disease. Psychol. Med. 9, 611–618.

Y. Barak , A. Achiron , M. Mandel , I. Mirecki , D. Aizenberg (2005) Reduced cancer incidence among patients with schizophrenia. Cancer 104, 2817–2821.

R. Basu , J. S. Brar , K. N. Chengappa et al. (2004) The prevalence of the metabolic syndrome in patients with schizoaffective disorder–bipolar subtype. Bipolar Disord. 6, 314–318.

D. Baxter , L. Appleby (1999) Case register study of suicide risk in mental disorders. Br. J. Psychiatry 175, 322–326.

J. G. Beaumont , S. J. Dimond (1973) Brain disconnection and schizophrenia. Br. J. Psychiatry 123, 661–662.

R. M. Benca , W. H. Obermeyer , R. A. Thisted , J. C. Gillin (1992) Sleep and psychiatric disorders: a meta-analysis. Arch. Gen. Psychiatry 49, 651–668.

B. E. Bennedsen (1998) Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophr. Res. 33, 1–26.

B. E. Bennedsen , P. B. Mortensen , A. V. Olesen , T. B. Henriksen (1999) Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br. J. Psychiatry 175, 239–245.

B. E. Bennedsen , P. B. Mortensen , A. V. Olesen , T. B. Henriksen (2001a) Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch. Gen. Psychiatry 58, 674–679.

B. E. Bennedsen , P. B. Mortensen , A. V. Olesen , T. B. Henriksen , M. Frydenberg (2001b) Obstetric complications in women with schizophrenia. Schizophr. Res. 47, 167–175.

L. Bernstein , R. K. Ross , M. C. Pike , J. B. Brown , B. E. Henderson (1990) Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br. J. Cancer 61, 298–302.

M. Bilici , H. Cakirbay , M. Guler et al. (2002) Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int. J. Neurosci. 112, 817–828.

J. R. Bishop , B. Alexander , B. C. Lund , T. B. Klepser (2004) Osteoporosis screening and treatment in women with schizophrenia: a controlled study. Pharmacotherapy 24, 515–521.

H. Blackburn , A. Keys , E. Simonson , P. Rautaharju , S. Punsar (1960) Electrocardiogram in population studies. Circulation 21, 1160–1175.

M. B. Blank , D. S. Mandell , L. Aiken , T. R. Hadley (2002) Co-occurrence of human immunodeficiency virus and serious mental illness among Medicaid recipients. Psychiatr. Serv. 53, 868–873.

R. Blumensohn , D. Ringler , I. Eli (2002) Pain perception in patients with schizophrenia. J. Nerv. Ment. Dis. 190, 481–483.

W. W. Bonney , S. Gupta , D. R. Hunter , S. Arndt (1997) Bladder dysfunction in schizophrenia. Schizophr. Res. 25, 243–249.

C. R. Bowie , P. D. Harvey (2005) Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr. Clin. North Am. 28, 613–633, 626.

P. Bracken , P. Coll (1985) Homocystinuria and schizophrenia: literature review and case report. J. Nerv. Ment. Dis. 173, 51–55.

A. J. Bremner , A. Regan (1991) Intoxicated by water: polydipsia and water intoxication in a mental handicap hospital. Br. J. Psychiatry 158, 244–250.

S. Brown (1997) Excess mortality of schizophrenia: a meta-analysis. Br. J. Psychiatry 171, 502–508.

S. Brown , J. Birtwistle , L. Roe , C. Thompson (1999) The unhealthy lifestyle of people with schizophrenia. Psychol. Med. 29, 697–701.

S. Brown , H. Inskip , B. Barraclough (2000) Causes of the excess mortality of schizophrenia. Br. J. Psychiatry 177, 212–217.

E. A. Burkitt , K. Khan (1973) Myasthenia gravis and schizophrenia: a rare combination. Br. J. Psychiatry 122, 735–736.

E. B. Campbell , S. Foley (2004) Coeliac disease and schizophrenia: data do not support hypothesis. Br. Med. J. 328, 1017.

C. M. Canuso , J. M. Goldstein , J. Wojcik et al. (2002) Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatr. Res. 111, 11–20.

F. Casadebaig , A. Philippe , J. M. Guillaud-Bataille et al. (1997) Schizophrenic patients: physical health and access to somatic care. Eur. Psychiatry 12, 289–293.

L. Chafetz , M. C. White , G. Collins-Bride , J. Nickens (2005) The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Commun. Ment. Health J. 41, 169–184.

S. Chaudhury , S. Chandra , M. Augustine (1994) Prevalence of Australia-antigen (Hbsag) in institutionalized patients with psychosis. Br. J. Psychiatry 164, 542–543.

C. H. Chen (1994) Seroprevalence of human immunodeficiency virus infection among Chinese psychiatric patients in Taiwan. Acta Psychiatr. Scand. 89, 441–442.

H. S. Cheng , L. C. Wang (2005) Intestinal parasites may not cause nosocomial infections in psychiatric hospitals. Parasitol. Res. 95, 358–362.

S. A. Chong , L. L. Tan , M. C. Wong et al. (1997) Disordered water homeostasis in Asian patients with schizophrenia. Aust. N. Z. J. Psychiatry 31, 869–873.

S. A. Chong , LumA. Mythily , H. Y. Goh , Y. H. Chan (2003) Prolonged QTc intervals in medicated patients with schizophrenia. Hum. Psychopharmacol. 18, 647–649.

I. J. Chopra , D. H. Solomon , T. S. Huang (1990) Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay. Metabolism 39, 538–543.

A. Cividini , A. Pistorio , A. Regazzetti et al. (1997) Hepatitis C virus infection among institutionalized psychiatric patients: a regression analysis of indicators of risk. J. Hepatol. 27, 455–463.

D. J. Clarke , M. E. Buckley (1989) Familial association of albinism and schizophrenia. Br. J. Psychiatry 155, 551–553.

C. V. Clevenger , P. A. Furth , S. E. Hankinson , L. A. Schuler (2003) The role of prolactin in mammary carcinoma. Endocr. Rev. 24, 1–27.

S. Cnattingius , J. L. Mills , J. Yuen , O. Eriksson , H. Salonen (1997) The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am. J. Obstet. Gynecol. 177, 156–161.

A. J. Cohen , F. J. Roe (2000) Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem. Toxicol. 38, 237–253.

K. L. Cohen , M. E. Swigar (1979) Thyroid function screening in psychiatric patients. J. Am. Med. Ass. 242, 254–257.

M. Cohen , B. Dembling , J. Schorling (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr. Res. 57, 139–146.

B. J. Cohler , D. H. Gallant , H. U. Grunebaum , J. L. Weiss , E. Gamer (1975) Pregnancy and birth complications among mentally ill and well mothers and their children. Soc. Biol. 22, 269–278.

C. Conejero-Goldberg , E. F. Torrey , R. H. Yolken (2003) Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr. Res. 60, 65–69.

A. F. Cooper (1976) Deafness and psychiatric illness. Br. J. Psychiatry 129, 216–226.

C. U. Correll , S. Leucht , J. M. Kane (2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am. J. Psychiatry 161, 414–425.

F. Cournos , K. McKinnon (1997) human immunodeficiency virus seroprevalence among people with severe mental illness in the United States: a critical review. Clin. Psychol. Rev. 17, 259–269.

J. Cradock-O'Leary , A. S. Young , E. M. Yano , M. M. Wang , M. L. Lee (2002) Use of general medical services by ventricular arrhythmia patients with psychiatric disorders. Psychiatr. Serv. 53, 874–878.

J. A. Cramer , R. Rosenheck (1998) Compliance with medication regimens for mental and physical disorders. Psychiatr. Serv. 49, 196–201.

I. Creese , A. P. Feinberg , S. H. Snyder (1976) Butyrophenone influences on the opiate receptor. Eur. J. Pharmacol. 36, 231–235.

S. M. Curkendall , J. Mo , D. B. Glasser , S. M. Rose , J. K. Jones (2004) Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J. Clin. Psychiatry 65, 715–720.

S. O. Dalton , L. T. Munk , L. Mellemkjaer , C. Johansen , P. B. Mortensen (2003) Schizophrenia and the risk for breast cancer. Schizophr. Res. 62, 89–92.

S. O. Dalton , T. M. Laursen , L. Mellemkjaer , C. Johansen , P. B. Mortensen (2004) Risk for cancer in parents of patients with schizophrenia. Am. J. Psychiatry 161, 903–908.

S. O. Dalton , L. Mellemkjaer , L. Thomassen , P. B. Mortensen , C. Johansen (2005) Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969–1993. Schizophr. Res. 75, 315–324.

G. L. Daumit , R. W. Goldberg , C. Anthony et al. (2005) Physical activity patterns in adults with severe mental illness. J. Nerv. Ment. Dis. 193, 641–646.

G. L. Daumit , P. J. Pronovost , C. B. Anthony et al. (2006) Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch. Gen. Psychiatry 63, 267–272.

A. David , A. Malmberg , G. Lewis , L. Brandt , P. Allebeck (1995) Are there neurological and sensory risk factors for schizophrenia? Schizophr. Res. 14, 247–251.

S. Davidson , F. Judd , D. Jolley et al. (2001) Cardiovascular risk factors for people with mental illness. Aust. N. Z. J. Psychiatry 35, 196–202.

G. C. Davis , M. S. Buchsbaum , D. Naber et al. (1982) Altered pain perception and cerebrospinal endorphins in psychiatric illness. Ann. N. Y. Acad. Sci. 398, 366–373.

M. A. Hert , R. Winkel , D. Eyck et al. (2006) Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr. Res. 83, 87–93.

J. Leon (2003) Polydipsia: a study in a long-term psychiatric unit. Eur. Arch. Psychiatr Clin. Neurosci. 253, 37–39.

J. Leon , F. J. Diaz (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76, 135–157.

J. Leon , C. Verghese , J. I. Tracy , R. C. Josiassen , G. M. Simpson (1994) Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol. Psychiatry 35, 408–419.

J. Leon , M. Dadvand , C. Canuso et al. (1996) Polydipsia and water intoxication in a long-term psychiatric hospital. Biol. Psychiatry 40, 28–34.

J. Leon , J. Tracy , E. McCann , A. McGrory (2002) Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr. Res. 57, 293–301.

A. Santis , G. Addolorato , A. Romito et al. (1997) Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J. Intern. Med. 242, 421–423.

R. Delaplaine , O. I. Ifabumuyi , H. Merskey , J. Zarfas (1978) Significance of pain in psychiatric hospital patients. Pain 4, 361–366.

L. E. Delisi , S. B. Smith , J. R. Hamovit et al. (1986) Herpes simplex virus, cytomegalovirus and Epstein–Barr virus antibody titres in sera from schizophrenic patients. Psychol. Med. 16, 757–763.

N. J. Delva , J. L. Crammer , S. V. Jarzylo et al. (1989) Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia. Biol. Psychiatry 26, 781–793.

M. M. Desai , R. A. Rosenheck , B. G. Druss , J. B. Perlin (2002) Mental disorders and quality of diabetes care in the veterans health administration. American Journal of Psychiatry 159, 1584–1590.

M. J. Dewan , P. A. Bick (1985) Normal pressure hydrocephalus and psychiatric patients. Biol. Psychiatry 20, 1127–1131.

F. B. Dickerson , C. H. Brown , J. Kreyenbuhl et al. (2004) Sexual and reproductive behaviors among persons with mental illness. Psychiatr. Serv. 55, 1299–1301.

F. B. Dickerson , C. H. Brown , G. L. Daumit et al. (2006) Health status of individuals with serious mental illness. Schizophr. Bull. 32, 584–589.

J. W. Dickerson , J. Wiryanti (1978) Pellagra and mental disturbance. Proc. Nutr. Soc. 37, 167–171.

R. A. Dickson , W. M. Glazer (1999) Neuroleptic-induced hyperprolactinemia. Schizophr. Res. 35 (Suppl.), S75–S86.

L. Dixon , L. Postrado , J. Delahanty , P. J. Fischer , A. Lehman (1999) The association of medical comorbidity in schizophrenia with poor physical and mental health. J. Nerv. Ment. Dis. 187, 496–502.

L. Dixon , P. Weiden , J. Delahanty et al. (2003) Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr. Bull. 26, 903–912.

F. C. Dohan , J. C. Grasberger (1973) Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. Am. J. Psychiatry 130, 685–688.

F. C. Dohan , J. C. Grasberger , F. M. Lowell , H. T. Johnston ., A. W. Arbegast (1969) Relapsed schizophrenics: more rapid improvement on a milk- and cereal-free diet. Br. J. Psychiatry 115, 595–596.

W. Dorrell (1973) Myasthenia gravis and schizophrenia. Br. J. Psychiatry 123, 249.

R. E. Drake , S. D. Rosenberg , K. T. Mueser (1996) Assessing substance use disorder in persons with severe mental illness. New Dir. Ment. Health Serv. 70, 3–17.

R. H. Dworkin (1994) Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr. Bull. 20, 235–248.

W. W. Eaton , C. Hayward , R. Ram (1992) Schizophrenia and rheumatoid arthritis: a review. Schizophr. Res. 6, 181–192.

W. W. Eaton , P. B. Mortensen , E. Agerbo et al. (2004) Coeliac disease and schizophrenia: population-based case control study with linkage of Danish national registers. Br. Med. J. 328, 438–439.

W. W. Eaton , M. Byrne , H. Ewald et al. (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163, 521–528.

O. F. Ehrentheil (1957) Common medical disorders rarely found in psychotic patients. Am. Med. Assoc. Arch. Neurol. Psychiatry 77, 178–186.

C. Enger , L. Weatherby , R. F. Reynolds , D. B. Glasser , A. M. Walker (2004) Serious cardiovascular events and mortality among patients with schizophrenia. J. Nerv. Ment. Dis. 192, 19–27.

L. Erlenmeyer-Kimling (1968) Mortality rates in the offspring of schizophrenic parents and a physiological advantage hypothesis. Nature 220, 798–800.

R. C. Evenson , C. J. Jos , A. R. Mallya (1987) Prevalence of polydipsia among public psychiatric patients. Psychol. Rep. 60, 803–807.

H. Ewald , P. B. Mortensen , O. Mors (2001) Decreased risk of acute appendicitis in patients with schizophrenia or manic-depressive psychosis. Schizophr. Res. 49, 287–293.

B. Fellerhoff , B. Laumbacher , R. Wank (2005) High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. Med. Hypotheses 65, 243–252.

I. N. Ferrier (1985) Water intoxication in patients with psychiatric illness. Br. Med. J. (Clin. Res. Edn) 291, 1594–1596.

R. Filik , A. Sipos , P. G. Kehoe et al. (2006) The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr. Scand. 113, 298–305.

D. P. Folsom , M. McCahill , S. Bartels et al. (2002) Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatri. Serv. 53, 1456–1460.

B. H. Fox , M. A. Howell (1974) Cancer risk among psychiatric patients: a hypothesis. Int. J. Epidemiol. 3, 207–208.

A. H. Friedlander , S. R. Marder (2002) The psychopathology, medical management and dental implications of schizophrenia. J. Am. Dent. Assoc. 133, 603–610.

A. M. Ghadirian , G. Chouinard , L. Annable (1982) Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J. Nerv. Ment. Dis. 170, 463–467.

K. H. Gingell , J. S. Darley , C. A. Lengua , P. Baddela (1993) Menstrual changes with antipsychotic drugs. Br. J. Psychiatry 162, 127.

N. L. Gittleson , T. D. Richardson (1973) Myasthenia gravis and schizophrenia: a rare combination. Br. J. Psychiatry 122, 343–344.

D. C. Goff , L. M. Sullivan , J. P. McEvoy et al. (2005) A comparison of ten-year cardiac risk estimates in schizophrenia patients from the Clinical Trials of Antipsychotic Treatment Effectiveness study and matched controls. Schizophr. Res. 80, 45–53.

V. Goffin , P. Touraine , C. Pichard , S. Bernichtein , P. A. Kelly (1999) Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol. Cell. Endocrinol. 151, 79–87.

M. J. Goldacre , L. M. Kurina , D. Yeates , V. Seagroat , L. Gill (2000) Use of large medical databases to study associations between diseases. Q. J. Med. 93, 669–675.

M. J. Goldacre , L. M. Kurina , C. J. Wotton , D. Yeates , V. Seagroat (2005) Schizophrenia and cancer: an epidemiological study. Br. J. Psychiatry 187, 334–338.

W. Goldfarb (1958) Pain reactions in a group of institutionalized schizophrenic children. Am. J. Orthopsychiatry 28, 777–785.

S. H. Goodman , E. K. Emory (1992) Perinatal complications in births to low socioeconomic status schizophrenic and depressed women. J. Abnorm. Psychol. 101, 225–229.

D. Grady , S. M. Rubin , D. B. Petitti et al. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117, 1016–1037.

D. Gregg (1939) The paucity of arthritis among psychotic cases. Am. J. Psychiatry 95, 853–858.

A. Grinshpoon , M. Barchana , A. Ponizovsky et al. (2005) Cancer in schizophrenia: is the risk higher or lower? Schizophr. Res. 73, 333–341.

S. Gupta , P. S. Masand , D. Kaplan , A. Bhandary , S. Hendricks (1997) The relationship between schizophrenia and irritable bowel syndrome (irritable bowel syndrome). Schizophr. Res. 23, 265–268.

U. Halbreich , S. Palter (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr. Bull. 22, 447–454.

U. Halbreich , N. Rojansky , S. Palter et al. (1995) Decreased bone mineral density in medicated psychiatric patients. Psychosom. Med. 57, 485–491.

U. Halbreich , B. J. Kinon , J. A. Gilmore , L. S. Kahn (2003) Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 28 (Suppl. 1), 53–67.

P. E. Halonen , R. Rimon , K. Arohonka , V. Jantti (1974) Antibody levels to herpes simplex type I, measles and rubella viruses in psychiatric patients. Br. J. Psychiatry 125, 461–465.

E. C. Harris , B. Barraclough (1998) Excess mortality of mental disorder. Br. J. Psychiatry 173, 11–53.

G. Harrison , D. Owens , A. Holton , D. Neilson , D. Boot (1988) A prospective study of severe mental disorder in Afro-Caribbean patients. Psychol. Med. 18, 643–657.

I. Harvey , M. Williams , P. McGuffin , B. K. Toone (1990) The functional psychoses in Afro-Caribbeans. Br. J. Psychiatry 157, 515–522.

K. Hatta , T. Takahashi , H. Nakamura et al. (1998) Abnormal physiological conditions in acute schizophrenic patients on emergency admission: dehydration, hypokalemia, leukocytosis and elevated serum muscle enzymes. Eur. Arch. Psychiatr. Clin. Neurosci. 248, 180–188.

T. Heiskanen , L. Niskanen , R. Lyytikainen , P. I. Saarinen , J. Hintikka (2003) Metabolic syndrome in patients with schizophrenia. J. Clin. Psychiatry 64, 575–579.

S. Hennessy , W. B. Bilker , J. S. Knauss et al. (2002) Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. Br. Med. J. 325, 1070.

H. Hinterhuber , L. Lochenegg (1975) [Gastric ulcers, stress and schizophrenia: incidence of gastric ulcers in male schizophrenic patients.] Arch. Psychiatr. Nervenkr. 220, 335–345.

A. Hoffer (1970) Pellagra and schizophrenia. Psychosomatics 11, 522–525.

R. I. Holt , R. C. Peveler , C. D. Byrne (2004) Schizophrenia, the metabolic syndrome and diabetes. Diabet. Med. 21, 515–523.

P. Homel , D. Casey , D. B. Allison (2002) Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophr. Res. 55, 277–284.

D. F. Horrobin , A. I. Ally , R. A. Karmali et al. (1978) Prostaglandins and schizophrenia: further discussion of the evidence. Psychol. Med. 8, 43–48.

R. G. Hoskins , F. H. Sleeper (1933) Organic functions in schizophrenia. Arch. Neurol. Psychiat. 30, 123–140.

L. Howard , N. Shah , M. Salmon , L. Appleby (2003) Predictors of social services supervision of babies of mothers with mental illness after admission to a psychiatric mother and baby unit. Soc. Psychiatry Psychiatr. Epidemiol. 38, 450–455.

R. H. Howland (1990) Schizophrenia and amyotrophic lateral sclerosis. Compr. Psychiatry 31, 327–336.

C. C. Hsiao , S. C. Ree , Y. L. Chiang , S. S. Yeh , C. K. Chen (2004) Obesity in schizophrenic outpatients receiving antipsychotics in Taiwan. Psychiatry Clin. Neurosci. 58, 403–409.

M. Hummer , P. Malik , R. W. Gasser et al. (2005) Osteoporosis in patients with schizophrenia. Am. J. Psychiatry 162, 162–167.

C. F. Hung , C. K. Wu , P. Y. Lin (2005) Diabetes mellitus in patients with schizophrenia in Taiwan. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 523–527.

A. E. Hussar (1965) Coronary heart disease in chronic schizophrenic patients: a clinicopathologic study. Circulation 31, 919–929.

A. E. Hussar (1968) Peptic ulcer in long-term institutionalized schizophrenic patients. Psychosom. Med. 30, 374–377.

A. V. Jablensky , V. Morgan , S. R. Zubrick , C. Bower , L. A. Yellachich (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am. J. Psychiatry 162, 79–91.

A. Jara-Prado , P. Yescas , F. J. Sanchez et al. (2000) Prevalence of acute intermittent porphyria in a Mexican psychiatric population. Arch. Med. Res. 31, 404–408.

D. V. Jeste , J. A. Gladsjo , L. A. Lindamer , J. P. Lacro (1996) Medical comorbidity in schizophrenia. Schizophr. Bull. 22, 413–430.

S. D. Jeste , T. L. Patterson , B. W. Palmer et al. (2003) Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr. Res. 63, 49–58.

L. E. Jones , W. Clarke , C. P. Carney (2004) Receipt of diabetes services by insured adults with and without claims for mental disorders. Med. Care 42, 1167–1175.

R. Kaelbling , J. B. Craig , B. Pasamanick (1961) Urinary porphobilinogen: results of screening 2500 psychiatric patients. Arch. Gen. Psychiatry 5, 494–508.

H. S. Kaplan , C. J. Sager , S. Schwartz , A. Kaye , G. B. Glass (1970) Post-gastrectomy pain and schizophrenia. Psychosomatics 11, 157–163.

E. J. Keely , J. P. Reiss , D. T. Drinkwater , C. Faiman (1997) Bone mineral density, sex hormones, and long-term use of neuroleptic agents in men. Endocrinol. Pract. 3, 209–213.

D. L. King , S. J. Cooper , J. A. Earle et al. (1985) A survey of serum antibodies to eight common viruses in psychiatric patients. Br. J. Psychiatry 147, 137–144.

T. Kishimoto , K. Watanabe , H. Takeuchi et al. (2005) Bone mineral density measurement in female inpatients with schizophrenia. Schizophr. Res. 77, 113–115.

D. L. Kleinberg , J. M. Davis , R. Coster , B. Baelen , M. Brecher (1999) Prolactin levels and adverse events in patients treated with risperidone. J. Clin. Psychopharmacol. 19, 57–61.

A. Klibanski , R. M. Neer , I. Z. Beitins et al. (1980) Decreased bone density in hyperprolactinemic women. N. Engl. J. Med. 303, 1511–1514.

F. H. Kooy (1919) Hyperglycemia in mental disorders. Brain 42, 214–288.

S. Korhonen , M. Hippelainen , L. Niskanen , M. Vanhala , S. Saarikoski (2001) Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am. J. Obstet. Gynecol. 184, 289–296.

Krakowski, A. J., Rydzynski, A., Jarosz, M., Engelsmann, F. (1983) Prevalence of psychosomatic disorders in schizophrenic patients in Poland. In Psychosomatic Medicine: Theoretical, Clinical and Transcultural Aspects, eds. A. J. Krakowski , R. Kimbal . New York: Plenum Press, 69–78.

J. Kroll (2001) Schizophrenia and liver dysfunction. Med. Hypotheses 56, 634–636.

H. Kunugi , S. Nanko , R. M. Murray (2001) Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br. J. Psychiatry (Suppl.) 40, S25–S29.

D. E. Laaksonen , H. M. Lakka , L. K. Niskanen et al. (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156, 1070–1077.

E. A. Lane , G. W. Albee (1970) The birth weight of children born to schizophrenic women. J. Psychol. 74, 157–160.

H. Lauerma , V. Lehtinen , M. Joukamaa et al. (1998) Schizophrenia among patients treated for rheumatoid arthritis and appendicitis. Schizophr. Res. 29, 255–261.

S. Lautenbacher , J. C. Krieg (1994) Pain perception in psychiatric disorders: a review of the literature. J. Psychiatr. Res. 28, 109–122.

D. M. Lawrence , C. D. Holman , A. V. Jablensky , T. J. Threlfall , S. A. Fuller (2000) Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr. Scand. 101, 382–388.

D. M. Lawrence , C. D. Holman , A. V. Jablensky , M. S. Hobbs (2003) Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998. Br. J. Psychiatry 182, 31–36.

S. M. Leucht , G. Pitschel-Walz , D. Abraham , W. Kissling (1999) Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis or randomized controlled trials. Schizophr. Res. 35, 51–68.

J. Levine , G. Agam , B. A. Sela et al. (2005a) cerebrospinal fluid homocysteine is not elevated in schizophrenia. J. Neur. Transm. 112, 297–302.

J. Levine , B. A. Sela , Y. Osher , R. H. Belmaker (2005b) High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1181–1191.

D. L. Levy , P. S. Holzman , L. R. Proctor (1983) Vestibular dysfunction and psychopathology. Schizophr. Bull. 9, 383–438.

R. P. Levy , J. B. Jensen , V. G. Laus , D. P. Agle , I. M. Engel (1981) Serum thyroid hormone abnormalities in psychiatric disease. Metabolism 30, 1060–1064.

S. Lewis , R. G. Jagger , E. Treasure (2001) The oral health of psychiatric in-patients in South Wales. Spec. Care Dentist. 21, 182–186.

D. Lichtermann , J. Ekelund , E. Pukkala , A. Tanskanen , J. Lonnqvist (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry 58, 573–578.

C. C. Lin , Y. M. Bai , J. Y. Chen , C. Y. Lin , T. H. Lan (1999) A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr. Scand. 100, 158–161.

H. Liu-Seifert , B. J. Kinon , J. Ahl , S. Lamberson (2004) Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics. Ann. N. Y. Acad. Sci. 1032, 297–298.

M. Llovera , C. Pichard , S. Bernichtein et al. (2000) Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 19, 4695–4705.

J. W. Lovett Doust (1980) Sinus tachycardia and abnormal cardiac rate variation in schizophrenia. Neuropsychobiology 6, 305–312.

E. Lycke , R. Norrby , B. E. Roos (1974) A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br. J. Psychiatry 124, 273–279.

S. Macdonald , J. Halliday , T. MacEwan et al. (2003) Nithsdale Schizophrenia Surveys 24: sexual dysfunction – case-control study. Br. J. Psychiatry 182, 50–56.

W. Magharious , D. C. Goff , E. Amico (1998) Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatr. Res. 77, 159–166.

E. Marchand Walter (1955) Occurrence of painless myocardial infarction in psychotic patients. N. Engl. J. Med. 253, 51–55.

E. Marchand Walter , B. Sarota , H. C. Marble et al. (1959) Occurrence of painless acute surgical disorders in psychotic patients. N. Engl. J. Med. 260, 580–585.

J. Marcus , J. Auerbach , L. Wilkinson , C. M. Burack (1981) Infants at risk for schizophrenia: the Jerusalem Infant Development Study. Arch. Gen. Psychiatry 38, 703–713.

S. R. Marder , S. M. Essock , A. L. Miller et al. (2004) Physical health monitoring of patients with schizophrenia. Am. J. Psychiatry 161, 1334–1349.

P. R. Mason , F. E. Winton (1995) Ear disease and schizophrenia: a case-control study. Acta Psychiatr. Scand. 91, 217–221.

E. Masterson , B. O'Shea (1984) Smoking and malignancy in schizophrenia. Br. J. Psychiatry 145, 429–432.

R. G. McCreadie (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br. J. Psychiatry 183, 534–539.

R. G. McCreadie , H. Stevens , J. Henderson et al. (2004) The dental health of people with schizophrenia. Acta Psychiatr. Scand. 110, 306–310.

S. McDermott , R. Moran , T. Platt et al. (2005) Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Commun. Ment. Health J. 41, 747–755.

D. G. McLarty , W. A. Ratcliffe , J. G. Ratcliffe , J. G. Shimmins , A. Goldberg (1978) A study of thyroid function in psychiatric in-patients. Br. J. Psychiatry 133, 211–218.

T. F. McNeil , L. Kaij (1973) Obstetric complications and physical size of offspring of schizophrenic, schizophrenic-like, and control mothers. Br. J. Psychiatry 123, 341–348.

T. F. McNeil , L. Kaij , A. Malmquist-Larsson et al. (1983) Offspring of women with nonorganic psychoses: development of a longitudinal study of children at high risk. Acta Psychiatr. Scand. 68, 234–250.

A. M. Meaney , V. O'Keane (2002) Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia. Life Sci. 71, 979–992.

A. M. Meaney , S. Smith , O. D. Howes et al. (2004) Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br. J. Psychiatry 184, 503–508.

G. W. Mellsop , L. Koadlow , J. Syme , S. Whittingham (1974) Absence of rheumatoid arthritis in schizophrenia. Aust. N. Z. J. Med. 4, 247–252.

E. Mercier-Guidez , G. Loas (2000) Polydipsia and water intoxication in 353 psychiatric inpatients: an epidemiological and psychopathological study. Eur. Psychiatry 15, 306–311.

J. M. Meyer , C. E. Koro (2004) The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr. Res. 70, 1–17.

J. M. Meyer , C. E. Koro , G. J. L'Italien (2005) The metabolic syndrome and schizophrenia: a review. Int. Rev. Psychiatry 17, 173–180.

G. K. Mirdal , S. A. Mednick , F. Schulsinger , F. Fuchs (1974) Perinatal complications in children of schizophrenic mothers. Acta Psychiatr. Scand. 50, 553–568.

T. Miyaoka , H. Seno , M. Itoga et al. (2000) Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J. Clin. Psychiatry 61, 868–871.

K. Modrzewska (1980) The offspring of schizophrenic parents in a North Swedish isolate. Clin. Genet. 17, 191–201.

J. M. Monti , D. Monti (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med. Rev. 8, 133–148.

J. E. Morley , R. B. Shafer (1982) Thyroid function screening in new psychiatric admissions. Arch. Intern. Med. 142, 591–593.

O. Mors , P. B. Mortensen , H. Ewald (1999) A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr. Res. 40, 67–74.

P. B. Mortensen (1987) Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr. Scand. 75, 585–590.

P. B. Mortensen (1989) The incidence of cancer in schizophrenic patients. J. Epidemiol. Commun. Health 43, 43–47.

P. B. Mortensen (1992) Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr. Scand. 85, 390–393.

P. B. Mortensen (1994) The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 12, 185–194.

S. Mukherjee , P. Decina , V. Bocola , F. Saraceni , P. L. Scapicchio (1996) Diabetes mellitus in schizophrenic patients. Compr. Psychiatry 37, 68–73.

N. Muller , P. Schiller , M. Ackenheil (1991) Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 24, 225–228.

P. Munck-Jorgensen , O. Mors , P. B. Mortensen , H. Ewald (2000) The schizophrenic patient in the somatic hospital. Acta Psychiatr. Scand. (Suppl.) 102, 96–99.

J. W. Muntjewerff , H. J. Blom (2005) Aberrant folate status in schizophrenic patients: what is the evidence? Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1133–1139.

G. M. Murphy ., K. O. Lim , M. Wieneke et al. (1998) No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biol. Psychiatry 43, 205–209.

D. Naber , F. G. Pajonk , C. Perro , B. Lohmer (1994) Human immunodeficiency virus antibody test and seroprevalence in psychiatric patients. Acta Psychiatr. Scand. 89, 358–361.

U. Naidoo , D. C. Goff , A. Klibanski (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology 28 (Suppl. 2), 97–108.

Y. Nakamura , M. Koh , E. Miyoshi et al. (2004) High prevalence of the hepatitis C virus infection among the inpatients of schizophrenia and psychoactive substance abuse in Japan. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 591–597.

E. Negulici , D. Christodorescu (1967) Paranoid schizophrenia and Klinefelter's syndrome. Psychiatr. Neurol. (Basel)154, 27–36.

J. W. Newcomer , D. W. Haupt , R. Fucetola et al. (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch. Gen. Psychiatry 59, 337–345.

G. Nicholson , L. I. Liebling , R. A. Hall (1976) Thyroid dysfunction in female psychiatric patients. Br. J. Psychiatry 129, 236–238.

E. Nilsson , P. Lichtenstein , S. Cnattingius , R. M. Murray , C. M. Hultman (2002) Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr. Res. 58, 221–229.

J. Nordenberg , E. Fenig , M. Landau , R. Weizman , A. Weizman (1999) Effects of psychotropic drugs on cell proliferation and differentiation. Biochem. Pharmacol. 58, 1229–1236.

H. Nyback , F. A. Wiesel , B. M. Berggren , T. Hindmarsh (1982) Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiatr. Scand. 65, 403–414.

V. O'Keane , A. M. Meaney (2005) Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia? J. Clin. Psychopharmacol. 25, 26–31.

R. J. Oken , M. Schulzer (1999) At issue: schizophrenia and rheumatoid arthritis – the negative association revisited. Schizophr. Bull. 25, 625–638.

D. P. Osborn , M. B. King , I. Nazareth (2003) Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice. Br. Med. J. 326, 1122–1123.

T. Ostbye , L. H. Curtis , L. E. Masselink et al. (2005) Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiol. Drug Saf. 14, 407–415.

E. Osterberg (1978) Schizophrenia and rheumatic disease: a study on the concurrence of inflammatory joint diseases and a review of 58 case-records. Acta Psychiatr. Scand. 58, 339–359.

A. Osterlind (1990) Malignant melanoma in Denmark: occurrence and risk factors. Acta Oncol. 29, 833–854.

S. S. Othman , K. K. Abdul , J. Hassan et al. (1994) High prevalence of thyroid function test abnormalities in chronic schizophrenia. Aust. N. Z. J. Psychiatry 28, 620–624.

G. Oxenstierna , G. Bergstrand , L. Bjerkenstedt , G. Sedvall , G. Wik (1984) Evidence of disturbed cerebrospinal fluid circulation and brain atrophy in cases of schizophrenic psychosis. Br. J. Psychiatry 144, 654–661.

R. S. Paffenberger , C. H. Steinmetz , B. G. Pooler , R. T. Hyde (1961) The picture puzzle of the postpartum psychosis. J. Chronic Dis. 13, 161–173.

B. A. Palmer , V. S. Pankratz , J. M. Bostwick (2005) The lifetime risk of suicide in schizophrenia: a re-examination. Arch. Gen. Psychiatry 62, 247–253.

C. Paton , R. Esop , C. Young , D. Taylor (2004) Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatr. Scand. 110, 299–305.

V. N. Perisic , Z. Lopicic , G. Kokai (1990) Celiac disease and schizophrenia: family occurrence. J. Pediatr. Gastroenterol. Nutr. 11, 279.

T. L. Pilkington (1956) The coincidence of rheumatoid arthritis and schizophrenia. J. Nerv. Ment. Dis. 124, 604–606.

A. Preti , L. Cardascia , T. Zen et al. (2000) Risk for obstetric complications and schizophrenia. Psychiatr. Res. 96, 127–139.

I. Prohovnik , A. J. Dwork , M. A. Kaufman N. Willson (1993) Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 19, 805–816.

I. G. Pryce , H. Edwards (1966) Persistent oral dyskinesia in female mental hospital patients. Br. J. Psychiatry 112, 983–987.

P. Qin , H. Xu , T. M. Laursen , M. Vestergaard , P. B. Mortensen (2005) Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population-based cohort study. Br. Med. J. 331, 23.

N. Ragins , J. Schachter , E. Elmer et al. (1975) Infants and children at risk for schizophrenia: environmental and developmental observations. J. Am. Acad. Child Psychiatry 14, 150–177.

R. A. Ramsay , J. Ananth , F. Engelsmann et al. (1982) Schizophrenia and psychosomatic illness. J. Psychosom. Res. 26, 33–42.

W. A. Ray , S. Meredith , P. B. Thapa et al. (2001) Antipsychotics and the risk of sudden cardiac death. Arch. Gen. Psychiatry 58, 1161–1167.

W. T. Regenold , R. K. Thapar , C. Marano , S. Gavirneni , P. V. Kondapavuluru (2002) Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 70, 19–26.

J. G. Reilly , S. A. Ayis , I. N. Ferrier , S. J. Jones , S. H. Thomas (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355, 1048–1052.

R. O. Rieder , D. Rosenthal , P. Wender , H. Blumenthal (1975) The offspring of schizophrenics. 1. Fetal and neonatal deaths. Arch. Gen. Psychiatry 32, 200–211.

R. O. Rieder , S. H. Broman , D. Rosenthal (1977) The offspring of schizophrenics. 2. Perinatal factors and IQ. Arch. Gen. Psychiatry 34, 789–799.

A. T. Riggs , M. W. Dysken , S. W. Kim , J. A. Opsahl (1991) A review of disorders of water homeostasis in psychiatric patients. Psychosomatics 32, 133–148.

L. M. Riscalla (1980) Blindness and schizophrenia. Med. Hypotheses 6, 1327–1328.

A. H. Robins (1972) Phenothiazine melanosis in schizophrenic patients. Psychopharmacologia 27, 327–342.

R. P. Roca , M. R. Blackman , M. B. Ackerley , S. M. Harman , R. I. Gregerman (1990) Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocr. Res. 16, 415–447.

P. E. Rodgers-Johnson , F. W. Hickling , A. Irons et al. (1996) Retroviruses and schizophrenia in Jamaica. Mol. Chem. Neuropathol. 28, 237–243.

D. P. Rose , B. T. Pruitt (1981) Plasma prolactin levels in patients with breast cancer. Cancer 48, 2687–2691.

S. H. Rosenthal , K. A. Porter , B. Coffey (1990) Pain insensitivity in schizophrenia: case report and review of the literature. Gen. Hosp. Psychiatry 12, 319–322.

W. D. Ross , J. Hay , M. F. McDowall (1950) The association of certain vegetative disturbances with various psychoses. Psychosom. Med. 12, 170–183.

N. O. Rothermich , V. K. Philips (1963) Rheumatoid arthritis in criminal and mentally ill populations. Arthritis Rheum. 6, 639–640.

A. Ruigomez , L. A. Garcia Rodriguez , V. J. Dev , F. Arellano , J. Raniwala (2000) Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology 11, 620–623.

M. C. Ryan , P. Collins , J. H. Thakore (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 160, 284–289.

W. G. Ryan , R. F. Roddam , W. E. Grizzle (1994) Thyroid function screening in newly admitted psychiatric inpatients. Ann. Clin. Psychiatry 6, 7–12.

J. Rybakowski , B. Romanski , M. Dabkowska , P. Grabowski , A. Krymer (1992) Allergic skin reactions in schizophrenia and affective disorders. Biol. Psychiatry 31, 1181–1182.

K. Saari ., J. Jokelainen , J. Veijola et al. (2004) Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey. Acta Psychiatr. Scand. 110, 279–285.

K. M. Saari , S. M. Lindeman , K. M. Viilo et al. (2005) A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study. J. Clin. Psychiatry 66, 559–563.

P. S. Sachdev (1998) Schizophrenia-like psychosis and epilepsy: the status of the association. Am. J. Psychiatry 155, 325–336.

P. S. Sachdev (2000) The current status of tardive dyskinesia. Aust. N. Z. J. Psychiatry 34, 355–369.

A. Sacker , D. J. Done , T. J. Crow (1996) Obstetric complications in children born to parents with schizophrenia: a meta-analysis of case-control studies. Psychol. Med. 26, 279–287.

A. J. Sameroff , M. Zax (1973) Perinatal characteristics of the offspring of schizophrenic women. J. Nerv. Ment. Dis. 157, 191–199.

A. E. Scheflen (1951) Malignant tumors in the institutionalized psychotic population. Arch. Neurol. Psychiatry 66, 145–155.

E. W. Schubert , T. F. McNeil (2004) Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. Am. J. Psychiatry 161, 1030–1037.

E. W. Schubert , G. Blennow , T. F. McNeil (1996) Wakefulness and arousal in neonates born to women with schizophrenia: diminished arousal and its association with neurological deviations. Schizophr. Res. 22, 49–59.

G. Secreto , C. Recchione , A. Cavalleri , M. Miraglia , V. Dati (1983) Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br. J. Cancer 47, 269–275.

D. D. Sewell (1996) Schizophrenia and human immunodeficiency virus. Schizophr. Bull. 22, 465–473.

R. I. Shader , L. Grinspoon (1970) The effect of social feedback on chronic schizophrenic patients. Compr. Psychiatry 11, 196–199.

B. M. Sibai , T. Gordon , E. Thom et al. (1995) Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study – The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Am. J. Obstet. Gynecol. 172, 642–648.

C. Silberstein , M. Galanter , M. Marmor et al. (1994) human immunodeficiency virus-1 among inner city dually diagnosed inpatients. Am. J. Drug Alcohol Abuse 20, 101–113.

T. Silverstone , G. Smith , E. Goodall (1988) Prevalence of obesity in patients receiving depot antipsychotics. Br. J. Psychiatry 153, 214–217.

M. K. Singh , L. L. Giles , H. A. Nasrallah (2006) Pain insensitivity in schizophrenia: trait or state marker? J. Psychiatr. Pract. 12, 90–102.

M. M. Singh , S. R. Kay (1976) Wheat gluten as a pathogenic factor in schizophrenia. Science 191, 401–402.

D. S. Siscovick , T. E. Raghunathan , B. M. Psaty et al. (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N. Engl. J. Med. 330, 1852–1857.

F. H. Sleeper (1935) Investigation of polyuria in schizophrenia. Am. J. Psychiatry 91, 1019–1031.

S. M. Smith , V. O'Keane , R. Murray (2002) Sexual dysfunction in patients taking conventional antipsychotic medication. Br. J. Psychiatry 181, 49–55.

D. E. Sobel (1961) Children of schizophrenic patients: preliminary observations on early development. Am. J. Psychiatry 118, 512–517.

D. I. Spratt , A. Pont , M. B. Miller et al. (1982) Hyperthyroxinemia in patients with acute psychiatric disorders. Am. J. Med. 73, 41–48.

H. L. Stanley , B. P. Schmitt , R. M. Poses , W. P. Deiss (1991) Does hypogonadism contribute to the occurrence of a minimal trauma hip tracture in elderly men? J. Am. Geriatr. Soc. 39, 766–771.

T. Steinert , M. Wolfersdorf , H. Thoma , M. Marpert (1996) [Does long-term hospitalization modify cardiovascular morbidity in schizophrenic patients?] Fortschr. Neurol. Psychiatr. 64, 212–220.

F. M. Stevens , R. S. Lloyd , S. M. Geraghty et al. (1977) Schizophrenia and coeliac disease: the nature of the relationship. Psychol. Med. 7, 259–263.

E. Susser , E. Valencia , S. Conover (1993) Prevalence of human immunodeficiency virus infection among psychiatric patients in a New York City men's shelter. Am. J. Public Health 83, 568–570.

H. L. Sweetwood , D. F. Kripke , I. Grant , J. Yager , M. S. Gerst (1976) Sleep disorder and psychobiological symptomatology in male psychiatric outpatients and male nonpatients. Psychosom. Med. 38, 373–378.

O. Taieb , J. M. Baleyte , P. Mazet , A. M. Fillet (2001) Borna disease virus and psychiatry. Eur. Psychiatry 16, 3–10.

K. I. Takahashi , T. Shimizu , T. Sugita , (1998) Prevalence of sleep-related respiratory disorders in 101 schizophrenic inpatients. Psychiatr. Clin. Neurosci. 52, 229–231.

W. K. Tang , F. C. Sun , G. S. Ungvari , D. O'Donnell (2004) Oral health of psychiatric in-patients in Hong Kong. Int. J. Soc. Psychiatry 50, 186–191.

D. C. Taylor (2003) Schizophrenias and epilepsies: why? when? how? Epilepsy Behav. 4, 474–482.

S. Taylor (1984) Gilbert's syndrome as a cause of postoperative jaundice. Anaesthesia 39, 1222–1224.

D. I. Templer , G. G. Cappelletty , I. Kauffman (1988) Schizophrenia and multiple sclerosis: distribution in Italy. Br. J. Psychiatry 153, 389–390.

Terenius, L., Wahlstrom, A. (1978) Physiologic and clinical relevance of endorphins. In Centrally Acting Peptides, ed. J. Hughes Baltimore, MD: Baltimore University Park Press, pp. 161–178.

M. A. Test , L. S. Wallisch , D. J. Allness , K. Ripp (1989) Substance abuse in young adults with schizophrenic disorders. Schizophr. Bull. 15, 465–476.

C. E. Teunissen , J. Vente , H. W. Steinbusch , C. Bruijn (2002) Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol. Aging 23, 485–508.

J. H. Thakore , J. N. Mann , I. Vlahos , A. Martin , R. Reznek (2002) Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int. J. Obes. Relat Metab. Disord. 26, 137–141.

F. M. Theisen , A. Linden , F. Geller et al. (2001) Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. J. Psychiatr. Res. 35, 339–345.

A. Thomas , E. Lavrentzou , C. Karouzos , C. Kontis (1996) Factors which influence the oral condition of chronic schizophrenia patients. Spec. Care Dentist 16, 84–86.

E. F. Torrey , R. H. Yolken (2001) The schizophrenia–rheumatoid arthritis connection: infectious, immune, or both? Brain Behav. Immun. 15, 401–410.

E. F. Torrey , R. H. Yolken (2003) Toxoplasma gondii and schizophrenia. Emerg. Infect. Dis. 9, 1375–1380.

R. W. Turkington (1972) Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa. Arch. Intern. Med. 130, 349–354.

E. Velasco , G. Machuca , A. Martinez-Sahuquillo et al. (1997) Dental health among institutionalized psychiatric patients in Spain. Spec. Care Dentist 17, 203–206.

W. V. Vieweg , J. J. David , J. L. Glick et al. (1986) Polyuria among patients with psychosis. Schizophr. Bull. 12, 739–743.

W. V. Vieweg , J. J. David , W. T. Rowe et al. (1985) Death from self-induced water intoxication among patients with schizophrenic disorders. J. Nerv. Ment. Dis. 173, 161–165.

K. Viskum (1975) Mind and ulcer. Acta Psychiatr. Scand. 51, 182–200.

J. Volavka , A. Convit , P. Czobor et al. (1991) human immunodeficiency virus seroprevalence and risk behaviors in psychiatric inpatients. Psychiatr. Res. 39, 109–114.

J. P. Warner , T. R. Barnes , J. A. Henry (1996) Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr. Scand. 93, 311–313.

G. D. Watson , P. C. Chandarana , H. Merskey (1981) Relationships between pain and schizophrenia. Br. J. Psychiatry 138, 33–36.

R. Webb , K. Abel , A. Pickles , L. Appleby (2005) Mortality in offspring of parents with psychotic disorders: a critical review and meta-analysis. Am. J. Psychiatry 162, 1045–1056.

U. Wesselmann , K. Windgassen (1995) Galactorrhea: subjective response by schizophrenic patients. Acta Psychiatr. Scand. 91, 152–155.

T. Wetterling , S. Pest , H. Mussigbrodt , B. Weber (2004) [Bodyweight in inpatients with schizophrenia.] Psychiatr. Prax. 31, 250–254.

K. E. White , J. L. Cummings (1996) Schizophrenia and Alzheimer's disease: clinical and pathophysiologic analogies. Compr. Psychiatry 37, 188–195.

A. Wieck , P. M. Haddad (2003) Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences – selective literature review. Br. J. Psychiatry 182, 199–204.

W. S. Wiedorn (1954) Toxemia of pregnancy and schizophrenia. J. Nerv. Ment. Dis. 120, 1–9.

K. Windgassen , U. Wesselmann , M. H. Schulze (1996) Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology. Neuropsychobiology 33, 142–146.

J. W. Winkelman (2001) Schizophrenia, obesity, and obstructive sleep apnea. J. Clin. Psychiatry 62, 8–11.

G. Wrede , S. A. Mednick , M. O. Huttunen , C. G. Nilsson (1980) Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers. Acta Psychiatr. Scand. 62, 369–381.

Y. Yase , N. Matsumoto , K. Azuma , Y. Nakai , H. Shiraki (1972) Amyotrophic lateral sclerosis: association with schizophrenic symptoms and showing Alzheimer's tangles. Arch. Neurol. 27, 118–128.

T. Young , M. Palta , J. Dempsey et al. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230–1235.

D. G. Zaridze , P. Boyle (1987) Cancer of the prostate: epidemiology and aetiology. Br. J. Urol. 59, 493–502.

M. Zax , A. J. Sameroff , H. M. Babigian (1977) Birth outcomes in the offspring of mentally disordered women. Am. J. Orthopsychiatry 47, 218–230.

J. H. Zhang-Wong , M. V. Seeman (2002) Antipsychotic drugs, menstrual regularity and osteoporosis risk. Arch. Women Ment. Health 5, 93–98.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 40 *
Loading metrics...

Book summary page views

Total views: 182 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 17th October 2017. This data will be updated every 24 hours.